Program Schedule

1264
Impact of the MIC: Vancomycin and Daptomycin

Session: Interactive Session: Which One is Best? Antibiotic Choice and Delivery Method in Unique Patients and Settings
Saturday, October 11, 2014: 9:10 AM
Room: The Pennsylvania Convention Center: Terrace Ballroom-I, II, III, IV
Keith Rodvold, Pharm D, University of Illinois at Chicago, Chicago, IL

Dr. Keith A. Rodvold received his BS (1978) and PharmD (1980) degrees from the University of Minnesota. He completed his research fellowship in clinical pharmacokinetics and pharmacology at St. Paul-Ramsey Medical Center and the University of Minnesota (1980-1981) and was a Clinical Pharmacy Specialist at St. Joseph’s Hospital in Marshfield, Wisconsin, from 1981 to 1984. Dr. Rodvold was appointed as an Assistant Professor in the Department of Pharmacy Practice at the University of Illinois at Chicago in 1984, was promoted to the rank of Associate Professor with tenure in 1989, and to the rank of Professor in 1994. In addition, he is also a Professor of Pharmacy in Medicine in the College of Medicine at the University of Illinois at Chicago. Dr. Rodvold is currently conducting research in the area of clinical pharmacokinetics and pharmacodynamics of anti-infective and chemoprevention agents, funded by the NCI/NIH and major pharmaceutical companies. Dr. Rodvold has authored more than 135 original research and review publications, 40 book chapters, and co-editor of the textbook, Drug Interactions in Infectious Diseases. The American College of Clinical Pharmacy presented Dr. Rodvold with the 2003 Russell R. Miller Award in recognition of his sustained and outstanding contributions to the literature of clinical pharmacy. Dr. Rodvold is a former member of the Anti-Infective Drug Advisory Committee and Pediatric Drug Advisory Subcommittee for the Food and Drug Administration. He is an active member of numerous professional societies and has been elected Fellow of the Infectious Diseases Society of America, American College of Clinical Pharmacology, and American College of Clinical Pharmacy.



Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

Sponsoring Societies:

© 2014, idweek.org. All Rights Reserved.

Follow IDWeek